MEIJI SEIKA PHARMATECH CO., LTD — Pravastatin Importer Profile
Pharmaceutical Importer · #4 buyer for Pravastatin · $2.0M import value · 40 shipments · JAPAN · DGFT Verified
MEIJI SEIKA PHARMATECH CO., LTD is the #4 importer of Pravastatin from India with $2.0M in import value and 40 verified shipments. MEIJI SEIKA PHARMATECH CO., LTD holds a 6.4% market share in Pravastatin imports based in JAPAN. The company sources from 1 verified supplier across 27 formulations shipped to 1 country.
MEIJI SEIKA PHARMATECH CO., LTD — Pravastatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Pravastatin to MEIJI SEIKA PHARMATECH CO., LTD?
Verified from 40 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDREICH LIMITED | $2.0M | 40 | 100.0% |
MEIJI SEIKA PHARMATECH CO., LTD sources Pravastatin from 1 verified Indian supplier based on 40 customs records. The primary supplier is MEDREICH LIMITED accounting for 100.0% of imports.
How Does MEIJI SEIKA PHARMATECH CO., LTD Compare to Nearest Pravastatin Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | GLENMARK PHARMACEUTICALS INC., USA | UNITED STATES | $2.3M | 45 | $50.0K |
| 6 | NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $1.2M | 27 | $42.8K |
| 4 | MEIJI SEIKA PHARMATECH CO., LTD ★ | JAPAN | $1.1M | 22 | $50.0K |
| 7 | ARROW PHARMACEUTICALS PTY LTD., | AUSTRALIA | $888.1K | 46 | $19.3K |
| 5 | MEIJI SEIKA PHARMATECH CO LIMITED | JAPAN | $650.0K | 13 | $50.0K |
MEIJI SEIKA PHARMATECH CO., LTD ranks #4 among 77 Pravastatin importers from India. Average shipment value of $50.0K compared to the market average of $133.0K. The closest competitors by value are GLENMARK PHARMACEUTICALS INC., USA and NORTHSTAR DISTRIBUTION CENTER 8912.
Where Does MEIJI SEIKA PHARMATECH CO., LTD Import Pravastatin To?
Destination countries from 40 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| JAPAN | $2.0M | 40 | 100.0% |
MEIJI SEIKA PHARMATECH CO., LTD imports Pravastatin to 1 country. The primary destination is JAPAN receiving 100.0% of shipments worth $2.0M.
What Pravastatin Formulations Does MEIJI SEIKA PHARMATECH CO., LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| PRAVASTATIN SODIUM 10MG TABLETS PO NO.M | $300.0K | 6 |
| PRAVASTATIN 10MGTABS 40000S-NN-NISSIN/JA | $200.0K | 4 |
| PRAVASTATIN SODIUM 5MG TABLETS, PO NO.MM | $181.7K | 4 |
| PRAVASTATIN 5MGTABS 70000S-NN-NISSIN/JAP | $100.0K | 2 |
| PRAVASTATIN SODIUM 10MG TABLETS, PO NO.M | $100.0K | 2 |
| PRAVASTATIN 5MG TABS 70000S-NN-NISSIN/JAPAN, PACK SIZE:70000S, QTY:65.157 | $50.0K | 1 |
| PRAVASTATIN 10MGTABS 40000S-NN-NISSIN/JAPAN, PO NO.MM-151, PACK SIZE:40000S, QTY:68.920 | $50.0K | 1 |
| PRAVASTATIN SODIUM 10MG TABLETS, PO NO.MM-152, PACK SIZE:40000S, QTY:120.025 | $50.0K | 1 |
| PRAVASTATIN SODIUM 5MG TABLETS PO NO.MM-153 PACK SIZE:70000S QTY:66.577 | $50.0K | 1 |
| PRAVASTATIN SODIUM 10MG TABLETS PO NO.MM-153 PACK SIZE:40000S QTY:69.799 | $50.0K | 1 |
MEIJI SEIKA PHARMATECH CO., LTD imports 27 distinct Pravastatin formulations from India. The top formulation is PRAVASTATIN SODIUM 10MG TABLETS PO NO.M with 6 shipments worth $300.0K.
Regulatory Requirements: Importing Pravastatin into Japan
What MEIJI SEIKA PHARMATECH CO., LTD and other importers must comply with to import Pravastatin from India
Regulatory Authority
Pharmaceuticals and Medical Devices Agency (PMDA)
Approval Process for Generic Pravastatin
Generic Drug Application under Japan Pharmaceutical Affairs Act. Requires dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Typical timeline: 12–24 months
GMP Requirements
Japanese GMP (J-GMP) compliance; PMDA on-site inspection of manufacturing facility
Import Licence & Documentation
Marketing Authorization Holder (MAH) must be a Japanese entity; Foreign Manufacturer Registration (Accreditation) required
Labeling & Packaging
Japanese language labeling mandatory; Japanese Pharmacopoeia compliance
Note: Japan requires Yen-denominated pricing approval (NHI drug price listing). Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available PMDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with PMDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Pravastatin from India and How Much Does MEIJI SEIKA PHARMATECH CO., LTD Import?
India exported $10.2M worth of Pravastatin through 634 shipments from 20 suppliers to 17 countries, serving 77 buyers globally. MEIJI SEIKA PHARMATECH CO., LTD imports $2.0M of this total, accounting for 6.4% of India's Pravastatin exports with 40 shipments from JAPAN. This is verified from 40 customs shipment records covering 27 distinct formulations.
What Is the Average Order Value for MEIJI SEIKA PHARMATECH CO., LTD's Pravastatin Imports?
MEIJI SEIKA PHARMATECH CO., LTD's average Pravastatin order value is $48.9K per consignment, based on 40 shipments totaling $2.0M. MEIJI SEIKA PHARMATECH CO., LTD is based in JAPAN and ranks #4 among all Pravastatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Pravastatin to MEIJI SEIKA PHARMATECH CO., LTD?
MEIJI SEIKA PHARMATECH CO., LTD sources Pravastatin from 1 verified Indian supplier: MEDREICH LIMITED ($2.0M, 100.0%). This is based on 40 customs records.
How Does MEIJI SEIKA PHARMATECH CO., LTD Compare to Other Pravastatin Importers?
MEIJI SEIKA PHARMATECH CO., LTD ranks #4 among 77 Pravastatin importers from India with a 6.4% market share. The top 3 importers are GLENMARK PHARMACEUTICALS INC., USA ($2.3M), NORTHSTAR DISTRIBUTION CENTER 8912 ($1.2M), MEIJI SEIKA PHARMATECH CO., LTD ($1.1M). MEIJI SEIKA PHARMATECH CO., LTD processed 40 shipments from JAPAN.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pravastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pravastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MEIJI SEIKA PHARMATECH CO., LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MEIJI SEIKA PHARMATECH CO., LTD's capped import value divided by total capped export value for Pravastatin across all Indian exporters.
- 5.Verified Records: This page is backed by 40 individual customs records matching MEIJI SEIKA PHARMATECH CO., LTD importing Pravastatin, covering 27 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 17+ countries, 77+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pravastatin Import Data for MEIJI SEIKA PHARMATECH CO., LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for MEIJI SEIKA PHARMATECH CO., LTD's Pravastatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MEIJI SEIKA PHARMATECH CO., LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
MEIJI SEIKA PHARMATECH CO., LTD × Pravastatin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MEIJI SEIKA PHARMATECH CO., LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pravastatin. For current order-level data, contact TransData Nexus.